Trinity Partners

Three Barriers to Biosimilar AdoptionUnderstanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.
Top 5 pipeline drugs for 2018
Top 5 pipeline drugs for 2018New blockbuster drugs to treat various conditions are expected to be among the top drugs to hit the marketplace in 2018. Here are 5 of the top new drugs in the pipeline for 2018, according to analysts.
Potential CVS-Aetna merger: Top 6 industry implicationsHealthcare executives identify how the industry could be affected if the Aetna-CVS merger goes through.
Potential CVS-Aetna merger: Key takeaways for health execsThe CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.